Shanghai CirCode Biomed Co. Ltd. (CirCode), an innovative biotech company pioneering circular RNA therapies, recently announced that its leading pipeline HM2002 received Investigational New Drug (IND) clearance from the US...

Leading international medical research company, MEDSIR announced today the positive results of the TUXEDO-3 trial at the American Society of Clinical Oncology (ASCO) Annual Meeting 2025. This phase II study funded by...

Amgen (NASDAQ:AMGN) will present at Jefferies Global Healthcare Conference at 9:20 a.m. ET on Wednesday, June 4, 2025. Peter Griffith, executive vice president and chief financial officer at Amgen, and Murdo Gordon,...

FARE (Food Allergy Research & Education) today announces its support for the American Center for Cures, a bipartisan effort to prevent and cure major diseases. Following FARE's inaugural Mind Meld Innovation...

Eli Lilly and Company (NYSE: LLY) today announced that data from studies of orforglipron, insulin efsitora alfa, tirzepatide (Zepbound and Mounjaro), retatrutide, eloralintide and bimagrumab will be presented at the...

Zenagen, the hair wellness brand disrupting the hair loss market with its clinically developed, plant-powered technology, is proud to announce that its flagship Revolve Shampoo for Women has officially been named the #1...

BLUETTI, a global leader in clean energy solutions, today announced a strategic partnership with the non-profit organization Footprint Project to tackle the upcoming hurricane and storm season head-on.

Sun Pharmaceutical Industries Limited (Reuters: SUN.BO, Bloomberg: SUNP IN, NSE: SUNPHARMA, BSE: 524715 (together with its subsidiaries and/or associated companies, "Sun Pharma")) today announced the successful completion...

Mabwell (688062.SH), an innovation-driven biopharmaceutical company with entire industry chain, announced that Albipagrastim alfa for Injection (trade name: MAILISHENG, R&D code: 8MW0511) developed by its wholly-owned...

Myeloid Therapeutics, Inc. ("Myeloid"), a clinical-stage immunology company advancing RNA therapeutics to conquer cancer, today announced it will present two posters at the 2025 American Society of Clinical Oncology (ASCO)...

Diakonos Oncology Corp., a clinical-stage biotechnology company developing a new generation of immunotherapies to treat challenging and aggressive cancers, today announced the closing of a $20 million private placement of...

With thousands of press releases published each week, it can be difficult to keep up with everything on PR Newswire. To help healthcare journalists and consumers stay on top of the week's most newsworthy and popular...

Haemonetics Corporation (NYSE: HAE) announced that Chris Simon, President and CEO, will participate in a fireside chat with investors at the Goldman Sachs 46th Annual Global Healthcare Conference on Monday, June 9, 2025 at...

GC Biopharma, a South Korean pharmaceutical company, announced that the Phase 3 clinical trial results for Hunterase (idursulfase beta), its investigational drug for Hunter Syndrome (MPS II), have been published in...

New Day Diagnostics today announced the launch of ColoHealth™, a groundbreaking blood test for colorectal cancer screening is now accessible to adults aged 50+ who are at average risk. This test offers a non-invasive...

SAN DIEGO, Calif., May 29, 2025 /PRNewswire/ - Sollus Health, a leader in non-invasive Transcranial Magnetic Stimulation "TMS" treatment in California, today announced the appointment of Amy Stickler, Director of Global...

During May's Mental Health Awareness Month, Cohen Veterans Network (CVN), a national not-for-profit network of mental health clinics for post-9/11 veterans, service members, and their families, continues its work to...

Concord Healthcare Group Co., Ltd. ("Concord Healthcare"), a subsidiary of Concord Medical Services Holdings Limited (the "Company") (NYSE: CCM), which subsidiary is listed on the Main Board of The Stock Exchange of Hong...

As new Gallup data from the Global Flourishing Study reveals that 44% of young adults worldwide feel they don't matter to others, The Dorm-a leading mental health treatment program-offers a message of hope. In its 2024...

Vizgen, Inc., a life sciences company advancing spatial multi-omics, today announced a strategic partnership with Hamamatsu Photonics K.K., a global leader in optical imaging technology. This collaboration integrates...

Canada's booming aesthetic market is showing no signs of slowing down, with non-invasive procedures driving demand and setting the stage for continued double-digit growth. Riding this momentum, North American...

In hospitals across the country, nurses are often asked to do more with less. At Mercy, leaders are asking a different question: How can we make the experience of being a nurse better?

Following a comprehensive search, Total Health Oncology has been selected as the exclusive provider for licensed ASCO Direct™ meetings in the United States.

Breakthrough T1D, formerly JDRF, the leading global type 1 diabetes (T1D) research and advocacy organization, is pleased to announce two exciting developments at the Breakthrough T1D Center of Excellence in New England...

MellingMedical today announced a new agreement with an industry leader in full-endoscopic and minimally invasive spinal surgery products, welcoming joimax® to its growing portfolio of cutting edge medical-surgical...

Ivím at Work, a joint solution from Ivím Health and Xevant, has been named the winner of the Gold Stevie® Award in the Consumer Products category in the 23rd Annual American Business Awards®. The American Business Awards...

Olympus Corp., a global medical technology company committed to making people's lives healthier, safer and more fulfilling, announced today the launch of the ScopeLocker Air endoscope drying cabinet, offering a new...

Investigators from Hackensack Meridian John Theurer Cancer Center (JTCC)-part of the National Cancer Institute-designated Lombardi Comprehensive Cancer Center at Georgetown University-and Hackensack University Medical...

HM King Frederik of Denmark presented neuroscientists, Professors Michelle Monje (USA) and Frank Winkler (Germany), with their Brain Prize medals and a diploma at a ceremony in Copenhagen Wednesday evening. The Brain Prize...

Angels for Change today announced that Fagron Sterile Services US (FSS) has been awarded a 2025 Project PROTECT grant to produce sterile water for injection (SWIFI), a critical component in the preparation of injectable...

Nextbiomedical announced today that its novel hemostatic powder, Nexpowder™, has been published in GUT (Impact Factor: 23), one of the world's most influential journals in gastroenterology. The large-scale randomized...

Findings from 34 clinical research studies conducted at Florida Cancer Specialists & Research Institute, LLC (FCS) are among the groundbreaking scientific advances in cancer care that will be featured as oncology...

Sera Prognostics Inc., The Pregnancy Company® (Nasdaq: SERA), focused on improving maternal and neonatal health by providing innovative pregnancy biomarker information to doctors and patients, today announced that members...

On May 20, Medicilon Preclinical Research (Shanghai) LLC ("Medicilon") announces that it has successfully passed an on-site inspection by the FDA. The company receives an official Establishment Inspection Report (EIR)...

Novavax, Inc. (Nasdaq: NVAX) today announced that it will participate in the following upcoming investor conferences:

The research reveals the challenges of introducing innovative medications in women's health in Canada

CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery using blood purification, today announced that management will present and...

Genprex, Inc. ("Genprex" or the "Company") (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes, today announced that it has been...

Lumeris, a leader in healthcare technology and services, today announced a strategic partnership with the MIT Computational Biology Lab led by Professor Manolis Kellis at the Massachusetts Institute of Technology (MIT)...

The WHO Foundation has launched an emergency fundraising appeal to protect the Global Measles and Rubella Laboratory Network (GMRLN), one of the "largest global surveillance system," which supports measles and rubella...

Superior HealthPlan ("Superior"), a leading managed care organization in Texas and a company of Centene (NYSE: CNC), has announced the latest recipients of its annual community and provider grant program. The $200,000 in...

Fangzhou Inc. ("Fangzhou" or the "Company") (06086.HK), a leader in Internet healthcare solutions, took center stage at the 4th Annual "Internet + Pharma" Service Innovation Conference, held during the 90th PHARMCHINA...

Stealth BioTherapeutics Inc. (the "Company" or "Stealth"), a clinical-stage biotechnology company focused on the discovery, development and commercialization of novel therapies for diseases involving mitochondrial...

The National Medical Products Administration has recently granted approval for Trastuzumab rezetecan, China's first domestically developed antibody-drug conjugate (ADC), for treatment of adult patients with...

Halia Therapeutics, a clinical-stage biopharmaceutical company pioneering therapies that target the innate immune system, announces that CEO Dr. David Bearss will serve as keynote speaker at the Med Investment Forum 2025....

Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncologic, autoimmune, cardiovascular...

Bio-Thera Solutions, Ltd (688177:SH), a commercial-stage biopharmaceutical company developing a pipeline of biosimilars and innovative assets and Hikma Pharmaceuticals PLC, along with its wholly owned subsidiary Hikma...

Gilgamesh Pharmaceuticals, a clinical-stage neuroscience company developing innovative, best-in-class new chemical entities (NCEs) that transform the treatment paradigm for psychiatric diseases, today announced Phase 2a...

Indivior PLC (Nasdaq/LSE: INDV) today announced the appointment of Patrick Barry as Chief Commercial Officer, effective June 2. In this role, Barry will lead the company's commercial growth strategy, execution, and...

Kyverna Therapeutics, Inc. (Kyverna, Nasdaq: KYTX), a clinical-stage biopharmaceutical company focused on developing cell therapies for patients with autoimmune diseases, today announced that Warner Biddle, Chief Executive...

Immunic, Inc. ("Immunic" or the "Company") (Nasdaq: IMUX), a biotechnology company developing a clinical pipeline of orally administered, small molecule therapies for chronic inflammatory and autoimmune diseases, today...

It might sound cliché, but Harriet Hawkins, RN, CCRN, CPN, CPEN, FAEN, didn't know what to expect when she began her nursing career.

Cizzle Bio, Inc., a biotechnology company pioneering innovative biomarker blood tests for early detection of lung and gastric cancers, has announced an agreement with Doctors Hospital in the Cayman Islands to provide its...

Aria Care Partners has named Scott Giaimo, M.S., D.P.M., ABLES to the position of Chief Medical Officer of Podiatry. In this role, Dr. Giaimo will oversee delivery and expansion of the company's onsite podiatry...

PartsSource, the leading technology and enterprise software platform for managing mission-critical healthcare equipment, announced the opening of its state-of-the-art Customer Experience Center at its headquarters in...

Retrieve Medical Holdings, Inc. (OTC Pink: RMHI), a leader in AI-driven medical data technology, and MyID (https://link.edgepilot.com/s/25b16c97/FrqV3ddqtUGLr0bVgrY7Gw?u=http://www.getmyid.com/), the nation's premier...

NorthStar Anesthesia, an industry leader in anesthesia care, in April began its new partnership with Tampa General Hospital (TGH) North to provide anesthesia care and management services at three TGH North facilities:...

Large-Scale Study Confirms CanScan® Test Accurately Detects Early-Stage Cancers From a Simple Blood Draw

Astellas Patient Centricity is pleased to announce the second annual Patient Advocacy Organization (PAO) Action Week™ taking place June 9-13, 2025. This community-driven initiative - coordinated by volunteer staff members...

Eurofins Viracor announced today the launch of its new quantitative real-time PCR assays for dimorphic fungi, a significant advancement in the rapid and accurate diagnosis of infections caused by Blastomyces spp.,...

Newport Academy, the nation's leading mental health treatment program for adolescents ages 12–18, reviewed data from its teen mental health outcomes and found significant improvements in depression and anxiety...

Octapharma has released the results from its prospective, randomized, double-blind, parallel group, crossover, placebo-controlled phase 3 study comparing the effectiveness of PANZYGA® (immune globulin intravenous, human -...

Helix, a leader in precision health, is announcing the release of a new suite of pharmacogenomics (PGx) tests, including a test designed to identify patients with DYPD gene variants who may be at increased risk for side...

STEMREGEN®, the leader in science-backed stem cell supplements that support the body's innate repair system, is proud to announce its return as Title Sponsor of the 2026 Biohacking Conference, hosted by Dave Asprey,...

Evommune, Inc., a clinical-stage biotechnology company developing innovative therapies for chronic inflammatory diseases, today announced positive top-line data from its Phase 2 trial of EVO756 in adults with chronic...

Mitsubishi Tanabe Pharma America, Inc. (MTPA) today announced that the U.S. Food and Drug Administration (FDA) has accepted the New Drug Application (NDA) resubmission for investigational ND0612, a 24-hours/day,...

Panome Bio, a leading provider of multi-omic services, has added transcriptional profiling to its suite of discovery tools. "The full-service RNAseq workflow is ideal for biomarker discovery and mechanism of action studies...

Alexandria Real Estate Equities, Inc. (NYSE: ARE), the first, preeminent, longest-tenured and pioneering owner, operator and developer of collaborative Megacampus™ ecosystems in AAA life science innovation cluster...

Spyre Therapeutics, Inc. (NASDAQ: SYRE) (the "Company" or "Spyre"), a clinical-stage biotechnology company advancing best-in-class antibody engineering, dose optimization, and rational therapeutic combinations for the...

Physicians affiliated with OneOncology partner practices, and the OneOncology Research Network (OneR), will present 23 research abstracts at the American Society of Clinical Oncology (ASCO) Annual Meeting 2025, May 30-June...

Waters Corporation (NYSE:WAT) today announced the launch of the BioResolve™ Protein A Affinity Columns with MaxPeak™ Premier Technology, providing precise titer measurements. This launch marks the first set of affinity...

International medical imaging IT and cybersecurity company Sectra (STO: SECT B) will provide a US health system with its enterprise imaging solution as a cloud service, Sectra One Cloud, including its AI service, Sectra...

Whitehawk Therapeutics, Inc. (Nasdaq: WHWK), an oncology therapeutics company applying advanced technologies to established tumor biology to efficiently deliver improved ADC cancer treatments, announced today its...

Taiwan-based Formosa Pharmaceuticals ("Formosa", 6838.TW) announced that the company has entered into an exclusive licensing agreement with Adalvo Limited ("Adalvo") in the European and Brazilian markets for exclusive...

The National University Centre for Organ Transplantation (NUCOT) has launched the inaugural Tree Planting Legacy Project, 'Tree of Life: Where New Life Takes Root' at the National University Hospital (NUH), to...

Innovating care solutions: purpose-driven innovations in a connected ecosystem

The Experimental Drug Development Centre (EDDC), Singapore's national platform for drug discovery and development, today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track Designation for...

CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on developing innovative CAR T-cell therapies, announces that the Center for Drug Evaluation (CDE) of China's National Medical Products...

Olympus, a global medical technology company committed to making people's lives healthier, safer and more fulfilling, announced today FDA 510(k) clearance of its EZ1500 series endoscopes featuring Extended Depth of...

ST. JOHN'S, NL, May 27, 2025 /PRNewswire/ - TxtSquad, an AI-powered patient engagement platform, is expanding its impact through a new partnership with the Coordinated Accessible National (CAN) Health Network to...

CeleCor Therapeutics has completed its multinational Phase 3 clinical trial of Disaggpro™ (zalunfiban), an investigational heart-attack drug designed for rapid use at first point of medical contact – including before...

Independence Blue Cross (IBX) is closing critical gaps in care and delivering impactful results with its expanded behavioral health services (which include services for both mental health and substance use disorder).

The recent announcement that a former president of the United States developed late-stage prostate cancer is a distressing reminder of the vulnerabilities present within the American healthcare system. While no one is...

WESTON, Fla., May 27, 2025 /PRNewswire/ - Apotex Corp. today announced the launch of nilotinib capsules, a generic version of Tasigna®, in the United States, with 180 days of exclusivity.

AbbVie (NYSE: ABBV) today announced that key data from its broad oncology portfolio will be showcased across multiple oral presentations and posters at the upcoming American Society of Clinical Oncology (ASCO) Annual...

Flora Code, the world's first activated probiotic, unveils three delicious new flavors and a fresh new look - featuring the same patented activation technology, now with enhanced solubility for even better absorption....

Abbott (NYSE: ABT) today announced the U.S. Food and Drug Administration (FDA) has approved the company's Tendyne™ transcatheter mitral valve replacement (TMVR) system to treat people with mitral valve disease. This...

Syra Health Corp. (OTCQB: SYRA) ("Syra Health" or the "Company"), a healthcare technology company dedicated to powering better health through innovative technology products and services, announced today that the Indiana...

At the 2025 Biohacking Conference, Lumati, a leader in science-driven longevity solutions, proudly announces a strategic partnership with PNOE, the forefront innovator in metabolic & VO2max analysis technology. This...

The START Center for Cancer Research ("START") and OneOncology today announced a strategic partnership to launch early phase clinical trial sites. The rollout includes the Los Angeles Cancer Network (LACN, California), The...

Avant Technologies, Inc. (OTCQB: AVAI) ("Avant" or the "Company"), and its JV partner, Ainnova Tech, Inc., (Ainnova), a leading healthcare technology company focused on revolutionizing early disease detection using...

Nyra Medical, a leading innovator in structural heart therapies, today announced two key executive appointments that further solidify the company's momentum as it advances its revolutionary Cardiac Leaflet Enhancer...

Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced the appointment of Kevin Thornal as Group President, Global Businesses and the Americas. Reporting to Chairman-Elect,...

AI Medical Technology (AIM) has received CE mark approval for Dermalyser, its diagnostic decision support tool for melanoma detection. Designed for use on smartphones attached to a dermatoscope, the AI-powered tool has...

Zylox-Tonbridge Medical Technology Co., Ltd. ("Zylox-Tonbridge" or the "Company") today announced that its proprietary ZYLOX Unicorn™ Vascular Closure Device (VCD) has received regulatory approval in Indonesia. This marks...

The Association of Marshall Scholars, together with the family of pioneering sound engineer Ray Dolby, announce the "Ray Dolby - Marshall Scholarship Fund," an endowment to support Marshall Scholars who will be completing...

Dizal (SSE:688192), a biopharmaceutical company committed to developing novel medicines for the treatment of cancer and immunological diseases, announced today that it will present latest clinical study results of its...